002100 Tecon Biology Co.Ltd
- 6.62
- +0.28+4.42%
Tecon Biology Co.Ltd News
Tecon Biology Co.Ltd: Announcement on the 2023 Profit Distribution Plan
Tiankang Biotech: Announcement on the completion of the controlling shareholder\'s plan to increase the company\'s shares
Tiankang Biotech: Announcement on the progress of the controlling shareholder\'s plan to increase the company\'s shares by half of the time
Tiankang Biotech: 2022 Annual Equity Distribution Implementation Notice
Tiankang Biotech: Announcement on Tiankang debt-to-share price adjustments
Tiankang Biotech: CITIC Construction Investment Securities Co., Ltd.\'s Sponsorship Summary Report on Tiankang Biotech\'s Non-public Offering of Shares
Tiankang Biotech: Announcement on the extension of the plan of the controlling shareholder, Xinjiang Production and Construction Corps State-owned Assets Management Co., Ltd., to increase the company\'s shares
Tiankang Biotech: Announcement on the Settlement of Some Non-public Stock Fundraising Projects and Permanently Supplementing Liquidity with Savings Raised
Tiankang Biotech: CITIC Construction Investment Securities Co., Ltd.\'s inspection opinion on the conclusion of Tiankang Biotech\'s non-public stock fundraising project and permanently replenishing working capital from savings raised
Tiankang Biotech: Announcement on 2022 Profit Distribution Plan
Tiankang Biotech: Notice on Unfreezing Company Shares Held by Shareholders Holding 5% or More
Tiankang Biotech: Announcement on the progress of the controlling shareholder's plan to increase the company's shares by half of the time
Tiankang Biotech: Announcement on the controlling shareholder's increase in the company's shares and subsequent plans to increase its holdings
Tiankang Biotech: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2022
Tiankang Biotech: Announcement on the completion of non-trading transfers of employees' stock ownership plan shares to holders' stock accounts
Tiankang Biotech: Announcement on the conversion of convertible corporate bonds to shares in the second quarter of 2022
Tiankang Biotech: Prompt Announcement on the Listing and Circulation of Non-public Issuance of Restricted Shares
Tiankang Biotech: Notice on Judicial Freezing of Company Shares Held by Shareholders Holding 5% or More
Tiankang Biotech: Notice on Judicial Freezing of Company Shares Held by Shareholders Holding 5% or More
Tiankang Biotech: Announcement on the conversion of convertible corporate bonds to shares in the first quarter of 2022
Analysis
Price Target
No Data
No Data